FERRIC CARBOXYMALTOSE 50mg. IP

Ferric Carboxymaltose is an intravenous iron replacement therapy used for the treatment of iron deficiency and iron deficiency anemia when oral iron preparations are ineffective, not tolerated, or when rapid iron replenishment is required. It is a stable iron complex that allows the controlled delivery of iron to the body's iron stores and erythropoietic tissues. Ferric Carboxymaltose has been shown to rapidly increase hemoglobin levels, replenish iron stores, and improve symptoms such as fatigue, weakness, and reduced physical performance associated with iron deficiency. Clinical studies have demonstrated its efficacy and safety across a variety of patient populations, including those with chronic kidney disease, inflammatory bowel disease, heart failure, and postpartum anemia. (Evstatiev et al., 2011; Moore et al., 2011) Its ability to deliver large doses in a single administration makes it a convenient and effective option for correcting iron deficiency and supporting faster recovery.